← Leaderboards
Kimberly Byrnes
Henry M. Jackson Fdn For The Adv Mil/Med
$2,092,036
Attributed
$2,627,286
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $502.9K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,627,286 · 4
By mechanism
R01$1,275,164 · 1
R21$849,224 · 2
R41$502,898 · 1
Top collaborators
- Lisa Ann Baker3 shared
- David James Sharp1 shared
Most similar at Henry M. Jackson Fdn For The Adv Mil/Med
Same institution · by research overlap
- Sean Collier$33,538
Others in their field
Top investigators on “Motor”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Jane S Paulsen · University Of Wisconsin-Madison$53,147,245
- Jerrold L Vitek · University Of Minnesota$52,399,244
- Merit E Cudkowicz · Massachusetts General Hospital$49,510,334
- Michael M Johns · Emory University$49,234,033
- David A Bennett · Rush University Medical Center$37,162,250
Research focus
MotorRattusRecovery Of FunctionUnited StatesInjuryAcuteRecoveryMicrogliaSensoryBladderSpinal Cord InjuryLesionSiteEnzymesSpinal CordTissuesHindlimbMagnetic Resonance ImagingAnti-Inflammatory AgentsPhenotypeReportingAnti-InflammatoryProductionInflammation
Grant awards (10)
Promoting tissue repair and functional recovery after spinal cord injury by targeting the microtubule regulatory protein Fidgetin-like 2.$458,154
R41 · FY2025 · NS
Promoting tissue repair and functional recovery after spinal cord injury by targeting the microtubule regulatory protein Fidgetin-like 2: Supplement for Imaging System$44,744
R41 · FY2025 · NS
FL2 siRNA as a Novel Therapeutic Option to Induce Spinal Cord Regeneration Following Injury$425,702
R21 · FY2022 · NS · contact PI
Intranasal insulin therapy for single and repeated mild traumatic brain injury$192,510
R21 · FY2017 · NS · contact PI
The NADPH oxidase enzyme as a therapeutic target after Spinal Cord Injury$236,384
R01 · FY2016 · NS · contact PI
Intranasal insulin therapy for single and repeated mild traumatic brain injury$231,012
R21 · FY2016 · NS · contact PI
The NADPH oxidase enzyme as a therapeutic target after Spinal Cord Injury$262,650
R01 · FY2015 · NS · contact PI
The NADPH oxidase enzyme as a therapeutic target after Spinal Cord Injury$260,023
R01 · FY2014 · NS · contact PI
The NADPH oxidase enzyme as a therapeutic target after Spinal Cord Injury$253,457
R01 · FY2013 · NS · contact PI
The NADPH oxidase enzyme as a therapeutic target after Spinal Cord Injury$262,650
R01 · FY2012 · NS · contact PI